Rain Oncology's Merger with Pathos AI: Pioneering the Future of Oncology with AI-Powered Solutions
In a significant development within the biotechnology industry, Rain Oncology Inc. (NASDAQ: RAIN) has announced its entry into a definitive merger agreement with Pathos AI Inc. (Pathos), a pioneering artificial intellig...
Dec 13, 2023
• Major Pharmaceutical Preparations Industry
Stock Market Announcement
